Literature DB >> 28926424

Introduction: Cancer as an Epigenetic Disease.

Jean-Pierre J Issa1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28926424      PMCID： PMC5708861          DOI： 10.1097/PPO.0000000000000285

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  16 in total

1.  Conrad Hal Waddington: the last Renaissance biologist?

Authors:  Jonathan M W Slack
Journal:  Nat Rev Genet       Date:  2002-11       Impact factor: 53.242

Review 2.  Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.

Authors:  Megan P Hitchins
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 3.  Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis.

Authors:  Jason Brocato; Max Costa
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

Review 4.  Cellular reprogramming technology for dissecting cancer epigenome in vivo.

Authors:  Kenji Ito; Yasuhiro Yamada
Journal:  Epigenomics       Date:  2017-06-27       Impact factor: 4.778

Review 5.  CpG island methylator phenotype in cancer.

Authors:  Jean-Pierre Issa
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

Review 6.  Targeting the cancer epigenome for therapy.

Authors:  Peter A Jones; Jean-Pierre J Issa; Stephen Baylin
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

7.  Transplantation of pluripotential nuclei from triploid frog tumors.

Authors:  R G McKinnell; B A Deggins; D D Labat
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

8.  Reprogramming of a melanoma genome by nuclear transplantation.

Authors:  Konrad Hochedlinger; Robert Blelloch; Cameron Brennan; Yasuhiro Yamada; Minjung Kim; Lynda Chin; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

9.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 10.  Epigenetics and phenotypic variation in mammals.

Authors:  Anne E Peaston; Emma Whitelaw
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957
View more
  3 in total

Review 1.  Epigenetic Drugs and Their Immune Modulating Potential in Cancers.

Authors:  Yingying Liang; Sevin Turcan
Journal:  Biomedicines       Date:  2022-01-19

2.  The Potential Role of Epigenetic Mechanisms in the Development of Retinitis Pigmentosa and Related Photoreceptor Dystrophies.

Authors:  Galina Dvoriantchikova; Karin Rose Lypka; Dmitry Ivanov
Journal:  Front Genet       Date:  2022-03-11       Impact factor: 4.599

Review 3.  Dynamic Signatures of the Epigenome: Friend or Foe?

Authors:  Marta Machnik; Urszula Oleksiewicz
Journal:  Cells       Date:  2020-03-07       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.